{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T07:26:35Z","timestamp":1751700395159},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,5,31]]},"DOI":"10.18632\/aging.203053","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:55:02Z","timestamp":1621536902000},"page":"14372-14384","source":"Crossref","is-referenced-by-count":7,"title":["Identification of novel hepatitis B virus therapeutic vaccine candidates derived from polymerase protein"],"prefix":"10.18632","volume":"13","author":[{"given":"Juzeng","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqiang","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Wenzhou People\u2019s Hospital, Wenzhou 325000, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanfan","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","article-title":"The changing epidemiology of liver diseases in the Asia-Pacific region.","volume":"1","author":"Ng","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure.","volume":"1","author":"Bertoletti","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"3","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B.","volume":"6","author":"Guo","year":"2017","journal-title":"Hepatology"},{"key":"4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S2468-1253(19)30190-6","article-title":"Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure.","volume":"4","author":"Mansouri","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.","volume":"15","author":"Protzer","year":"2019","journal-title":"Gastroenterology"},{"key":"6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrc.2016.16","article-title":"Vaccines for established cancer: overcoming the challenges posed by immune evasion.","volume":"1","author":"Melief","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy.","volume":"35","author":"T\u00fcreci","year":"2018","journal-title":"Science"},{"key":"8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2217\/fvl.14.113","article-title":"Unveiling the roles of HBV polymerase for new antiviral strategies.","volume":"1","author":"Hu","year":"2015","journal-title":"Future Virol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.","volume":"12","author":"Chen","year":"2004","journal-title":"Gastroenterology"},{"key":"10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/hep.26064","article-title":"Hepatitis B virus polymerase impairs interferon-\u03b1-induced STA T activation through inhibition of importin-\u03b15 and protein kinase C-\u03b4.","volume":"5","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/cmi.2014.79","article-title":"The immune tolerant phase of chronic HBV infection: new perspectives on an old concept.","volume":"1","author":"Kennedy","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"12","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/cmi.2015.64","article-title":"Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.","volume":"1","author":"Wang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"13","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1136\/gutjnl-2017-315588","article-title":"Poly I:C-based rHBVvac therapeutic vaccine eliminates HBV via generation of HBV-specific CD8effector memory T cells.","volume":"6","author":"Zhang","year":"2019","journal-title":"Gut"},{"key":"14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/hep.29239","article-title":"Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.","volume":"6","author":"Peng","year":"2017","journal-title":"Hepatology"},{"key":"15","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.4049\/jimmunol.1203449","article-title":"IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.","volume":"19","author":"Tian","year":"2013","journal-title":"J Immunol"},{"key":"16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and Tumor Necrosis Factor-\u03b1 Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.","volume":"15","author":"Malo","year":"2016","journal-title":"Gastroenterology"},{"key":"17","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/s0198-8859(00)00178-6","article-title":"Analysis of the distribution of HLA-A alleles in populations from five continents.","volume":"6","author":"Perez","year":"2000","journal-title":"Hum Immunol"},{"key":"18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/v9050112","article-title":"Analysis of Epitope-Based Vaccine Candidates against Hepatitis B Virus Polymerase Protein.","volume":"9","author":"Wu","year":"2017","journal-title":"Viruses"},{"key":"19","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.jhep.2016.02.016","article-title":"New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.","volume":"6","author":"Zoulim","year":"2016","journal-title":"J Hepatol"},{"key":"20","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jhep.2010.12.031","article-title":"Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges.","volume":"5","author":"Mancini-Bourgine","year":"2011","journal-title":"J Hepatol"},{"key":"21","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.addr.2009.07.001","article-title":"T cell epitope: friend or foe? Immunogenicity of biologics in context.","volume":"6","author":"De Groot","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.vaccine.2012.12.074","article-title":"A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.","volume":"3","author":"Protzer","year":"2013","journal-title":"Vaccine"},{"key":"23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jhep.2013.05.003","article-title":"Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.","volume":"5","author":"Gong","year":"2013","journal-title":"J Hepatol"},{"key":"24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/gutjnl-2018-317725","article-title":"A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice.","volume":"6","author":"Zhang","year":"2020","journal-title":"Gut"},{"key":"25","doi-asserted-by":"publisher","first-page":"e101904","DOI":"10.1371\/journal.pone.0101904","article-title":"A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.","volume":"9","author":"McHutchison","year":"2014","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/j.gastro.2019.03.044","article-title":"Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.","volume":"15","author":"Fisicaro","year":"2019","journal-title":"Gastroenterology"},{"key":"27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/liv.12530","article-title":"Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.","volume":"3","author":"Sung","year":"2015","journal-title":"Liver Int"},{"key":"28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1136\/gutjnl-2014-308041","article-title":"TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.","volume":"6","author":"Strub","year":"2015","journal-title":"Gut"},{"key":"29","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.vaccine.2015.10.108","article-title":"Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes.","volume":"3","author":"Yu","year":"2016","journal-title":"Vaccine"},{"key":"30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/jmv.21736","article-title":"Identification of a dengue virus-specific HLA-A*0201-restricted CD8+ T cell epitope.","volume":"8","author":"Jiang","year":"2010","journal-title":"J Med Virol"},{"key":"31","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges.","volume":"17","author":"Liu","year":"2005","journal-title":"J Immunol"},{"key":"32","doi-asserted-by":"publisher","first-page":"W525","DOI":"10.1093\/nar\/gks438","article-title":"Immune epitope database analysis resource.","volume":"4","author":"Peters","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations.","volume":"1","author":"Lund","year":"2003","journal-title":"Protein Sci"},{"key":"34","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkn202","article-title":"NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11.","volume":"3","author":"Nielsen","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.","volume":"6","author":"Sette","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"36","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries.","volume":"4","author":"Peters","year":"2008","journal-title":"Immunome Res"},{"key":"37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00251-010-0441-4","article-title":"NetCTLpan: pan-specific MHC class I pathway epitope predictions.","volume":"6","author":"Nielsen","year":"2010","journal-title":"Immunogenetics"},{"key":"38","doi-asserted-by":"publisher","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity.","volume":"9","author":"Peters","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","article-title":"approach for predicting toxicity of peptides and proteins.","volume":"8","author":"Raghava","year":"2013","journal-title":"PLoS One"},{"key":"40","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1021\/ct500592m","article-title":"Improved PEP-FOLD Approach for Peptide and Miniprotein Structure Prediction.","volume":"1","author":"Tuff\u00e9ry","year":"2014","journal-title":"J Chem Theory Comput"},{"key":"41","doi-asserted-by":"publisher","first-page":"W288","DOI":"10.1093\/nar\/gks419","article-title":"PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides.","volume":"4","author":"Tuff\u00e9ry","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"42","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.","volume":"3","author":"Olson","year":"2009","journal-title":"J Comput Chem"},{"key":"43","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3892\/ijo.2013.1834","article-title":"Two novel squamous cell carcinoma antigen-derived HLA-A*0201-binding peptides induceandCD8+ cytotoxic T lymphocyte responses.","volume":"4","author":"Wen","year":"2013","journal-title":"Int J Oncol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T17:24:38Z","timestamp":1625765078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,5,31]]}},"alternative-id":["203053","34016795"],"URL":"https:\/\/doi.org\/10.18632\/aging.203053","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]}}}